This report is being filed due to recurrent mitral regurgitation, with worsening heart failure, and kidney injury.Patient id: (b)(6).It was reported that on (b)(6) 2021, the patient presented with functional mitral regurgitation (mr) grade 4+ with mitral annular calcification.One mitraclip was successfully implanted, reducing the mr to grade 1+.On (b)(6) 2021, the patient was hospitalized with fluid overload and worsening heart failure.Pulmonary edema and bilateral pleural effusions were noted.The mitraclip remained well attached with a moderate, eccentric, posteriorly directed regurgitation.Medications were provided as treatment.On (b)(6) 2021, the patient was hospitalized for an acute kidney injury (aki) and worsening heart failure, status post a fall.Medications were provided as treatment.Severe mr was noted, despite the implanted clip.There was no device malfunction specified, however, per physician, the device was inadequate, and did not reduce the mr as expected.No additional information was provided regarding this issue.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the cause of the reported recurrent mitral regurgitation (mr) and mitral stenosis associated with elevated mean mitral valve gradient could not be determined.A cause of the worsening tricuspid regurgitation (tr) also could not be determined.The reported heart failure was due to worsening of existing condition.The reported pulmonary edema, pleural effusion and renal failure appear to be secondary to the heart failure.The reported patient effects of heart failure, mitral regurgitation, mitral stenosis, pulmonary edema and renal failure as listed in the mitraclip system instructions for use are known possible complications associated with mitraclip procedures.The reported medication required and hospitalization were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
Subsequent to the previous report, the additional information was received/added: on (b)(6) 2021, during hospitalization for fluid overload, worsening tricuspid regurgitation was noted.The left atrium was dilated and mitral regurgitation persisted.The mitral valve gradient was elevated.
|